Hawaii — drug testing employment law

At a glance: Hawaii

Overview: drug testing in Hawaii

Hawaii's substance abuse testing statute (Haw. Rev. Stat. § 329B-1 et seq.) is one of the most procedurally detailed in the country. It requires testing to follow SAMHSA-equivalent procedures (certified lab, chain of custody, confirmation testing, MRO review) and contains specific notice requirements. Hawaii has had a medical cannabis program since 2000 but has not legalized recreational use, though decriminalization measures have advanced.

Cannabis law and workplace testing

The Medical Use of Cannabis statute does not contain an express employment anti-discrimination provision. However, Hawaii's testing statute restricts random testing to certain contexts and requires procedural protections that exceed federal minimums for non-DOT private-sector testing. Recreational use is decriminalized but not legal for sales.

Specific testing rules in Hawaii

The table below summarizes how Hawaii typically treats four common workplace testing scenarios. Each row reflects the dominant statutory or case-law position; carve-outs (federal-contractor, DOT-regulated, safety-sensitive, etc.) may shift any individual analysis.

Federal overlay: DOT and federal contractors

In all U.S. states — including Hawaii — DOT-regulated employees (safety-sensitive roles in transportation industries under 49 CFR Part 40) and federal-contractor employees subject to the federal Drug-Free Workplace Act of 1988 are testable under federal rules regardless of state cannabis status or workplace-testing restrictions. State law cannot reduce federal testing obligations for these populations. Where state law otherwise restricts cannabis testing, the federal-overlay carve-out typically preserves the employer's authority for these federally affected roles.

For employers in Hawaii

Follow Haw. Rev. Stat. § 329B-1 et seq. procedural requirements: written policy, certified lab, confirmation testing, MRO review, and the specific notice requirements. Hawaii medical cannabis patients have limited statutory protection — consult counsel before adverse action on a cardholder.

• Written policy. Document the substances tested, the cutoff levels, the testing modalities (urine / oral fluid / hair), and the consequences of a non-negative result.
• Notice. Provide written notice before testing begins and obtain signed acknowledgement where the state requires it.
• Certified laboratory. Use a SAMHSA-certified or equivalent laboratory; document chain of custody.
• Confirmation testing. Confirm any non-negative initial result with mass-spectrometry (GC-MS or LC-MS/MS) before any adverse action.
• MRO review. Engage a qualified Medical Review Officer to review all non-negative results before reporting to the employer.
• Safety-sensitive designations. If the role is statutorily exempt as safety-sensitive, document the designation in writing using the state\'s statutory definition.
• Medical cannabis disclosures. Where state law provides patient protection, engage an interactive accommodation process before adverse action.

For workers in Hawaii

Hawaii's procedural testing protections are robust: confirmation testing and MRO review are statutorily required. Random testing is largely limited to safety-sensitive contexts. Medical cannabis patient protection is limited — document your status and any prescription medications with the MRO.

• Know the policy. Request a copy of your employer\'s written testing policy — it should specify when testing occurs, what is tested, and how to challenge a result.
• Disclose medications to the MRO, not the employer. The Medical Review Officer reviews non-negative results before they are reported and can resolve a legitimate prescription explanation.
• Document medical cannabis status. If you are a registered medical cannabis patient in a state with patient protection, document your status with HR before testing.
• Confirmation testing. Any non-negative initial result should be confirmed by GC-MS or LC-MS/MS before adverse action.
• Appeal rights. Many state statutes provide an appeals process — read your employer\'s policy carefully.

Key statutes and citations

The following statutory citations are the primary controlling authority for drug testing employment law in Hawaii. We provide citations only — confirm current text via your state legislature\'s codified statutes (or an authoritative legal research platform) before relying on this information.

• Substance Abuse Testing of Employees — Haw. Rev. Stat. § 329B-1 et seq.
• Medical Use of Cannabis — Haw. Rev. Stat. § 329-121 et seq.

Multi-state employers operating in Hawaii

A national or multi-state employer\'s policy that works in a permissive state (e.g., Alabama or Texas) may not be lawful as applied to employees in Hawaii, and vice versa. Common multi-state pitfalls include: applying a national pre-employment cannabis screen in jurisdictions that prohibit it; treating a positive cannabis test as automatic disqualification where state law restricts that outcome; failing to designate safety-sensitive roles in compliance with the relevant state\'s statutory definition; and not maintaining state-specific written policies and acknowledgements. For multi-state programs, see our multi-state employer guide.

How this page is built and reviewed

This page combines a structured data layer (cannabis status, statutory protection levels, voluntary program details, statute citations) with state-specific narrative drafted from primary statutes and authoritative secondary sources. Every claim should trace either to a statute citation, an authoritative secondary source (e.g., NCSL, EEOC, DOT, SHRM, ASAM), or general background knowledge clearly framed as such. The page is reviewed against the listed sources on each material amendment.

Found something out of date? Let us know — we update state pages as statutes and case law evolve.